Exclusive

Publication

Byline

Location

Telangana government to unveil new life sciences policy

India, March 13 -- Telangana is set to launch a dedicated Life Sciences policy in the coming weeks, marking a significant step towards strengthening the state's leadership in the sector. The announce... Read More


Department of Biotechnology and Assam govt sign historic MoU for Centre-State partnership under BioE3 Policy

India, March 13 -- The Department of Biotechnology (DBT) and the Government of Assam have signed a landmark Memorandum of Understanding (MoU) under the BioE3(Biotechnology forEconomy,Environment, andE... Read More


Shilpa Medicare secures regulatory Nod for nor-ursodeoxycholic acid tablets, targets market launch for NASH treatment

India, March 13 -- image credit- shutterstock Raichur-basedShilpa Medicare Limited, a leading API and formulation manufacturer, has announced that the Subject Expert Committee (SEC) of the Central Dr... Read More


Zydus invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease

India, March 13 -- image credit- shutterstock Zynext VenturesUSALLC (Zynext Ventures), the venture capital arm of Ahmedabad-based Zydus Lifesciences, has announced its investment in US-based Illexcor... Read More


Tenthpin launches AI Labs (TAIL) in Hyderabad's Life Sciences Hub

India, March 13 -- image credit- shutterstock Switzerland based Tenthpin Management Consultants, a global consulting leader in technology advisory for life sciences companies, has announced the launc... Read More


Glenmark Pharma expands cardiometabolic portfolio with launch of Empagliflozin and FDCs in India

India, March 12 -- Mumbai-based Glenmark Pharmaceuticals, a research-led, global pharmaceutical company, has launched Empagliflozin, a widely recognized SGLT2 inhibitor, in India. The drug has been i... Read More


Alkem Labs launches generic empagliflozin and its combinations in India under brand name Empanorm

India, March 12 -- image credit- shutterstock Alkem Laboratories has announced the launch of Empanorm in India, a generic version of empagliflozin, for the treatment of type-2 diabetes mellitus, chro... Read More


Sartorius to expand Bengaluru's manufacturing capacity and enhance global supply chain capabilities

India, March 12 -- Based in Gottingen, Germany, Sartorius, a leading international partner of life sciences research and the biopharmaceutical industry has announced continued investments in its Banga... Read More


India's healthcare and pharma sector records deals over $30 B from 2022 to 2024

India, March 11 -- image credit- shutterstock Grant Thornton Bharat,in collaboration with theAssociation of Healthcare Providers India (AHPI),has released the report titled'Vitals for Growth: Decodin... Read More


Zydus to acquire majority stake in France-based Amplitude Surgical for €256.8 M

India, March 11 -- image credit- shutterstock Ahmedabad-based Zydus Lifescienceshas entered into exclusive negotiations to purchasefrom PAI Partners and Amplitude Surgical's management, as well as tw... Read More